Short answer
CODEXIS, INC. (CDXS) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Item 2.02 references Exhibit 99.1 for Codexis’s fiscal-year 2026 results.
CODEXIS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 references Exhibit 99.1 for Codexis’s fiscal-year 2026 results
- Earnings details require review of Exhibit 99.1; the provided text contains only filing-status language
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $14.9M versus $15.3M, while product revenue rose to $13.2M from $7.4M
- Product gross margin improved to 73% from 72%, reflecting stronger mix toward newer, higher-margin products
- Net loss narrowed to $12.0M, or $0.13 per share, from $13.3M, or $0.16 per share
- July equity financing added approximately $25M net, lifting pro forma cash to approximately $80M and extending operations funding through 2028
- 2026 guidance maintained at $72M-$76M revenue and high-60% gross margin, with ECO GMP production targeted by end-2027
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CODEXIS, INC. 8-K filings
Get the next CDXS 8-K as it lands
Follow CDXS for push alerts, or ask the research agent what this filing means.